Drugs Containing Excipient (Inactive Ingredient) SODIUM ALGINATE

Branded drugs containing SODIUM ALGINATE excipient, and estimated key patent expiration / generic entry dates

Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Pfizer Laboratories Div Pfizer Inc	CALAN SR	verapamil hydrochloride	0025-2712	SODIUM ALGINATE
AbbVie Inc	TARKA	trandolapril and verapamil hydrochloride	0074-3287	SODIUM ALGINATE
Haleon US Holdings LLC	NICORETTE	nicotine polacrilex	0135-0508	SODIUM ALGINATE
Haleon US Holdings LLC	NICORETTE	nicotine polacrilex	0135-0510	SODIUM ALGINATE
Haleon US Holdings LLC	NICORETTE	nicotine polacrilex	0135-0635	SODIUM ALGINATE

Generic drugs containing SODIUM ALGINATE excipient

Company	Ingredient	NDC	Excipient
Pfizer Laboratories Div Pfizer Inc	verapamil hydrochloride	0025-2712	SODIUM ALGINATE
Hikma Pharmaceuticals USA Inc	lithium carbonate	0054-0020	SODIUM ALGINATE
AbbVie Inc	trandolapril and verapamil hydrochloride	0074-3287	SODIUM ALGINATE
L Perrigo Company	nicotine polacrilex	0113-0344	SODIUM ALGINATE
L Perrigo Company	nicotine polacrilex	0113-0734	SODIUM ALGINATE

Market Overview and Financial Trajectory for Sodium Alginate

Last updated: February 7, 2026

Sodium alginate, a natural polysaccharide derived from brown seaweed, functions as a pharmaceutical excipient in drug delivery, wound dressings, and controlled-release products. Its usage spans multiple industries, including pharmaceuticals, food, cosmetics, and textiles. The compound’s market momentum stems from increased demand for biodegradable, natural excipients, coupled with expanding pharmaceutical applications.

---

Market Size and Growth Rate

• The global sodium alginate market was valued at approximately $860 million in 2021.
• It is projected to reach $1.2 billion by 2028, growing at a compound annual growth rate (CAGR) of about 5.4% from 2022 to 2028.
• The pharmaceutical sector accounts for roughly 25% of total sodium alginate consumption.

Key Drivers

• Increasing use in controlled-release drug formulations.
• Rising application in wound management and tissue engineering.
• Escalating demand for natural and biodegradable excipients.
• Expansion in emerging markets with growing healthcare infrastructure.

Regional Market Dynamics

Region	Share (2021)	CAGR (2022-2028)	Notable Trends
Asia-Pacific	45%	6.0%	Major producers include China, Indonesia, and the Philippines. Increasing pharmaceutical and food industry applications.
North America	25%	4.8%	Growth driven by pharmaceutical R&D and regulatory approvals for natural excipients.
Europe	20%	4.5%	Focus on sustainable excipients and innovation in drug delivery.
Rest of World	10%	5.2%	Increasing market penetration in Latin America and Middle East Asia.

Key Market Segments

• Pharmaceuticals: Utilized as a binder, disintegrant, stabilizer, and controlled-release agent.
• Food Industry: Employed as a thickening, gelling, and stabilizing agent.
• Other Sectors: Functions as a texturizer in cosmetics and as a sizing agent in textiles.

---

Major Industry Players

Company	Estimated Revenue (2021-2022)	Market Share	Notable Developments
FMC Corporation	$4.9 billion in 2022	15%	Expanding capacity for pharmaceutical-grade sodium alginate.
Cargill Incorporated	Private; estimates at $19 billion annual revenue	Significant global presence	Investing in sustainable seaweed sourcing.
DuPont de Nemours	Revenue approximately $44 billion in 2022	Noted for innovation in functional excipients	Developing high-purity grades for pharma.
KIMICA Corporation	Private; leading producer in Asia	Major supplier in Asia-Pacific	Focus on cost-efficient production methods.

Their strategies include capacity expansion, R&D for specialty-grade products, and regional market penetration.

---

Financial Trends and Investment Outlook

• Capital expenditure on plant upgrades and new extraction facilities is rising.
• Several companies report gross margins between 20% and 35% for sodium alginate segments, reflecting pricing power and operational efficiencies.
• Venture capital and private equity investments focus on sustainable seaweed cultivation and extraction technologies.
• Pricing remained relatively stable from 2018 to 2021, with slight increases in raw material costs translating to modest price adjustments for end-users.

Pricing Dynamics

• Average FOB (Free on Board) prices for pharmaceutical-grade sodium alginate range from $10 to $20 per kg, depending on purity and grade.
• Price volatility corresponds to seaweed harvests, supply chain disruptions, and regulatory changes affecting production costs.

Risks

• Fluctuations in seaweed harvests due to climate change influence raw material supply.
• Regulatory shifts regarding sustainable sourcing and traceability affect production costs.
• Competition from alternative natural excipients, such as pectin and carrageenan, constrains pricing power.

---

Key Takeaways

• The sodium alginate market is positioned for steady growth through 2028 driven by increased pharmaceutical and food sector demand.
• Asia-Pacific leads global consumption, supported by large-scale seaweed cultivation and expanding manufacturing capacity.
• Industry players focus on capacity expansion, product innovation, and sustainable sourcing to maintain competitive advantages.
• Pricing stability remains dependent on raw material supply chain resilience and regulatory developments.

---

Frequently Asked Questions

1. What factors influence sodium alginate pricing?

Raw material availability, seaweed harvest yields, environmental conditions, processing costs, and regulatory changes. Supply chain disruptions or raw material shortages increase prices.

2. Which geographic markets exhibit the highest growth potential?

Asia-Pacific, especially China and Indonesia, due to large-scale seaweed cultivation. Emerging markets in Latin America and Africa also present opportunities owing to increasing pharmaceutical R&D activity.

3. How is innovation impacting the sodium alginate market?

Development of high-purity, functional-grade sodium alginate tailored for specific pharmaceutical applications enhances market value. R&D efforts focus on improving extraction efficiency and sourcing sustainable raw materials.

4. What are the main competitive strategies employed by industry leaders?

Capacity expansion, technological innovations, sustainable sourcing practices, and regional market penetration.

5. How do regulatory frameworks impact the market?

Regulations promoting natural, biodegradable excipients support market expansion. Conversely, tightening sustainability standards may raise operational costs.

---

References

1. MarketsandMarkets. "Sodium Alginate Market by Application, Region – Global Forecast to 2028." 2022.
2. Grand View Research. "Sodium Alginate Market Size & Trends." 2022.
3. Cargill Corporate Reports. "Seaweed Sourcing and Sustainability Initiatives." 2022.
4. FMC Corporation Annual Report. 2022.
5. DuPont Innovation Press Release. "Developments in Pharmaceutical-Grade Sodium Alginate." 2022.